Open Access
SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis
3
Respiratory Medicine, Queen Elizabeth University Hospital, Glasgow, UK
|
6
First Division of Infectious Diseases, Cotugno Hospital, AORN Dei Colli, Naples, Italy
|
Publication type: Journal Article
Publication date: 2021-01-01
scimago Q1
wos Q1
SJR: 5.262
CiteScore: 25.4
Impact factor: 20.4
ISSN: 26665247
PubMed ID:
33521734
Microbiology (medical)
Microbiology
Infectious Diseases
Virology
Abstract
Viral load kinetics and duration of viral shedding are important determinants for disease transmission. We aimed to characterise viral load dynamics, duration of viral RNA shedding, and viable virus shedding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in various body fluids, and to compare SARS-CoV-2, SARS-CoV, and Middle East respiratory syndrome coronavirus (MERS-CoV) viral dynamics.In this systematic review and meta-analysis, we searched databases, including MEDLINE, Embase, Europe PubMed Central, medRxiv, and bioRxiv, and the grey literature, for research articles published between Jan 1, 2003, and June 6, 2020. We included case series (with five or more participants), cohort studies, and randomised controlled trials that reported SARS-CoV-2, SARS-CoV, or MERS-CoV infection, and reported viral load kinetics, duration of viral shedding, or viable virus. Two authors independently extracted data from published studies, or contacted authors to request data, and assessed study quality and risk of bias using the Joanna Briggs Institute Critical Appraisal Checklist tools. We calculated the mean duration of viral shedding and 95% CIs for every study included and applied the random-effects model to estimate a pooled effect size. We used a weighted meta-regression with an unrestricted maximum likelihood model to assess the effect of potential moderators on the pooled effect size. This study is registered with PROSPERO, CRD42020181914.79 studies (5340 individuals) on SARS-CoV-2, eight studies (1858 individuals) on SARS-CoV, and 11 studies (799 individuals) on MERS-CoV were included. Mean duration of SARS-CoV-2 RNA shedding was 17·0 days (95% CI 15·5-18·6; 43 studies, 3229 individuals) in upper respiratory tract, 14·6 days (9·3-20·0; seven studies, 260 individuals) in lower respiratory tract, 17·2 days (14·4-20·1; 13 studies, 586 individuals) in stool, and 16·6 days (3·6-29·7; two studies, 108 individuals) in serum samples. Maximum shedding duration was 83 days in the upper respiratory tract, 59 days in the lower respiratory tract, 126 days in stools, and 60 days in serum. Pooled mean SARS-CoV-2 shedding duration was positively associated with age (slope 0·304 [95% CI 0·115-0·493]; p=0·0016). No study detected live virus beyond day 9 of illness, despite persistently high viral loads, which were inferred from cycle threshold values. SARS-CoV-2 viral load in the upper respiratory tract appeared to peak in the first week of illness, whereas that of SARS-CoV peaked at days 10-14 and that of MERS-CoV peaked at days 7-10.Although SARS-CoV-2 RNA shedding in respiratory and stool samples can be prolonged, duration of viable virus is relatively short-lived. SARS-CoV-2 titres in the upper respiratory tract peak in the first week of illness. Early case finding and isolation, and public education on the spectrum of illness and period of infectiousness are key to the effective containment of SARS-CoV-2.None.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
5
10
15
20
25
30
|
|
|
Scientific Reports
26 publications, 2.34%
|
|
|
Viruses
23 publications, 2.07%
|
|
|
medRxiv : the preprint server for health sciences
19 publications, 1.71%
|
|
|
Science of the Total Environment
18 publications, 1.62%
|
|
|
PLoS ONE
17 publications, 1.53%
|
|
|
Journal of Medical Virology
16 publications, 1.44%
|
|
|
Nature Communications
16 publications, 1.44%
|
|
|
Clinical Infectious Diseases
15 publications, 1.35%
|
|
|
Journal of Infectious Diseases
14 publications, 1.26%
|
|
|
Open Forum Infectious Diseases
13 publications, 1.17%
|
|
|
Clinical Microbiology and Infection
12 publications, 1.08%
|
|
|
BMJ
12 publications, 1.08%
|
|
|
Frontiers in Public Health
11 publications, 0.99%
|
|
|
BMC Infectious Diseases
10 publications, 0.9%
|
|
|
International Journal of Infectious Diseases
9 publications, 0.81%
|
|
|
Microbiology spectrum
8 publications, 0.72%
|
|
|
Microorganisms
8 publications, 0.72%
|
|
|
International Journal of Molecular Sciences
7 publications, 0.63%
|
|
|
International Journal of Environmental Research and Public Health
6 publications, 0.54%
|
|
|
Vaccines
6 publications, 0.54%
|
|
|
Journal of Clinical Virology
6 publications, 0.54%
|
|
|
PLoS Computational Biology
6 publications, 0.54%
|
|
|
The Lancet Microbe
6 publications, 0.54%
|
|
|
eLife
6 publications, 0.54%
|
|
|
Epidemiology and Infection
6 publications, 0.54%
|
|
|
bioRxiv
6 publications, 0.54%
|
|
|
Proceedings of the National Academy of Sciences of the United States of America
6 publications, 0.54%
|
|
|
Nature Reviews Microbiology
5 publications, 0.45%
|
|
|
Journal of Virology
5 publications, 0.45%
|
|
|
5
10
15
20
25
30
|
Publishers
|
50
100
150
200
250
|
|
|
Elsevier
225 publications, 20.27%
|
|
|
Cold Spring Harbor Laboratory
162 publications, 14.59%
|
|
|
Springer Nature
139 publications, 12.52%
|
|
|
MDPI
92 publications, 8.29%
|
|
|
Oxford University Press
60 publications, 5.41%
|
|
|
Wiley
60 publications, 5.41%
|
|
|
Frontiers Media S.A.
35 publications, 3.15%
|
|
|
Public Library of Science (PLoS)
29 publications, 2.61%
|
|
|
Taylor & Francis
27 publications, 2.43%
|
|
|
American Society for Microbiology
27 publications, 2.43%
|
|
|
BMJ
25 publications, 2.25%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
15 publications, 1.35%
|
|
|
Royal Society of Chemistry (RSC)
12 publications, 1.08%
|
|
|
American Chemical Society (ACS)
12 publications, 1.08%
|
|
|
American Medical Association (AMA)
10 publications, 0.9%
|
|
|
Cambridge University Press
9 publications, 0.81%
|
|
|
The Royal Society
8 publications, 0.72%
|
|
|
SAGE
8 publications, 0.72%
|
|
|
Bentham Science Publishers Ltd.
6 publications, 0.54%
|
|
|
eLife Sciences Publications
6 publications, 0.54%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
6 publications, 0.54%
|
|
|
F1000 Research
5 publications, 0.45%
|
|
|
Walter de Gruyter
5 publications, 0.45%
|
|
|
Pleiades Publishing
5 publications, 0.45%
|
|
|
American Association for the Advancement of Science (AAAS)
5 publications, 0.45%
|
|
|
Centers for Disease Control and Prevention (CDC)
4 publications, 0.36%
|
|
|
JMIR Publications
4 publications, 0.36%
|
|
|
Baishideng Publishing Group
4 publications, 0.36%
|
|
|
AME Publishing Company
4 publications, 0.36%
|
|
|
50
100
150
200
250
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
1.1k
Total citations:
1111
Citations from 2024:
175
(15.77%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Cevik M. et al. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis // The Lancet Microbe. 2021. Vol. 2. No. 1. p. e13-e22.
GOST all authors (up to 50)
Copy
Cevik M., Tate M., Lloyd O., Maraolo A. E., Schafers J., Ho A. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis // The Lancet Microbe. 2021. Vol. 2. No. 1. p. e13-e22.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/S2666-5247(20)30172-5
UR - https://doi.org/10.1016/S2666-5247(20)30172-5
TI - SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis
T2 - The Lancet Microbe
AU - Cevik, Muge
AU - Tate, Matthew
AU - Lloyd, Ollie
AU - Maraolo, Alberto Enrico
AU - Schafers, Jenna
AU - Ho, Antonia
PY - 2021
DA - 2021/01/01
PB - Elsevier
SP - e13-e22
IS - 1
VL - 2
PMID - 33521734
SN - 2666-5247
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2021_Cevik,
author = {Muge Cevik and Matthew Tate and Ollie Lloyd and Alberto Enrico Maraolo and Jenna Schafers and Antonia Ho},
title = {SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis},
journal = {The Lancet Microbe},
year = {2021},
volume = {2},
publisher = {Elsevier},
month = {jan},
url = {https://doi.org/10.1016/S2666-5247(20)30172-5},
number = {1},
pages = {e13--e22},
doi = {10.1016/S2666-5247(20)30172-5}
}
Cite this
MLA
Copy
Cevik, Muge, et al. “SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis.” The Lancet Microbe, vol. 2, no. 1, Jan. 2021, pp. e13-e22. https://doi.org/10.1016/S2666-5247(20)30172-5.